Executive Management

Graham Mullis
Chief Executive Officer

  • Appointed CEO of Novacyt in 2014
  • Over 30 years in healthcare; pharmaceuticals & medical device markets
  • Internationally experienced leader with multi-disciplinary background
  • Led multiple successful exits; Biocompatibles Eyecare, ClearLab, VisionTec and Optivue
  • C-level executive with FTSE 250 (Biocompatibles International) and NASDAQ (1-800 CONTACTS)

James McCarthy
Chief Financial Officer

  • Appointed CFO of Novacyt in 2021
  • Over 30 years in international manufacturing and industrial businesses in both consumer and B2B
  • CFO in both Private Equity and public businesses.
  • FCCA qualified over 30 years with broad commercial, supply chain and M&A experience

Anthony Dyer
Chief Corporate Development Officer

  • Joined Novacyt in 2010
  • 18 years in healthcare; pharmaceuticals & medical devices
  • Growth business and M&A experience, including RiboTargets / British Biotech and BioFocus / Galapagos
  • FCCA qualified 20 years; commercial and audit background
  • 5 years as CFO for Novacyt, helping to deliver some significant milestones

Mandy Cowling
Corporate & Investor Relations Manager

  • Joined Novacyt in June 2012.
  • 21 years experience of working in multifaceted roles that encompass company secretarial, investor relations management and personal assistant duties, supporting company Directors and Senior Management.

Lisa Henriet
Group Operations Director

  • Joined Novacyt in May 2016
  • Over 25 years experience gained in a varied range of sectors at Senior and Executive Management lever within SME companies
  • Multifaceted roles encompassing finance, IT, Procurement, HR, Manufacturing, Logistics and Facilities Management
  • An improvement and change management professional

Steve Gibson
Group Finance Director

  • Joined Novacyt in April 2017
  • Over 12 years’ experience working at an internationally recognized blue-chip company
  • Trusted finance business partner for multi-billion dollar deals
  • CIMA qualified 10 years; commercial and financial management background
  • Lived & worked in the UAE

Paul Eros
Chief Business Officer

  • Joined Novacyt in November 2017
  • Over 30 years experience in molecular diagnostics, classical IVD markets and life science research with Becton Dickinson, Roche and DiaSorin
  • Globally experienced marketer and commercial leader

Navin Nauth-Misir
RA & QA Director

  • Joined Novacyt in May 2019
  • Over 30 years experience with medical devices and In Vitro Diagnostic medical devices
  • Experience in the NHS, regulatory authority and manufacturing companies
  • Extensive involvement in standards development and expert working groups
  • International regulatory expertise

Guillermo Raimondo
Chief Commercial Officer

  • Joined Novacyt in January 2021
  • Over 25 years in healthcare
  • Medical devices & services markets
  • Internationally experienced leader with multi-disciplinary background
  • Successful track record in driving customer facing organizations and different types and scale of business

R.A. Trevor
Chief Technical Officer

  • Joined Novacyt in January 2021
  • Over 25 years in healthcare
  • Diagnostics, Pharma and Biotech markets
  • Internationally experience leader with multi-disciplinary background
  • Successful track record of leading R&D organisations to develop innovative new products

Nick Plummer
General Counsel & Company Secretary

  • Joined Novacyt in April 2021
  • Corporate/commercial solicitor with over 25 years’ experience in large law firms (Ashurst, Keystone Law) and running in-house legal functions (Ark Therapeutics Group PLC and Patheon/Thermo Fisher Scientific), specialising in healthcare.
  • Prior to Novacyt, Nick spent eight years working as EU Managing Counsel for Patheon (then Thermo Fisher), supporting the drug product development and manufacture business.
  • Admitted as a solicitor in England and Wales.

David Franks 
Chief Human Resources Officer

  • Joined Novacyt in April 2021
  • 25 years corporate and advisory experience across a range of cultures and operating contexts
  • Track record of transformation and change, with a focus on scaling for growth and building organisational capability